GELS
BEARISH
$0.77
Live
Gelteq Limited · NASDAQ
$0.64
52W Range
$4.11
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
95%
GELS exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. While the company shows strong top-line revenue growth (59.40%) and healthy gross margins (72.07%), these are completely offset by a catastrophic operating margin of -2969.43%. With a current ratio of 0.27 and a quick ratio of 0.14, the company lacks the liquidity to meet its short-term obligations. Despite trading below book value (P/B 0.70), the fundamental instability and long-term price decay make this a high-risk speculative asset.
Key Strengths
Strong Gross Margin of 72.07%
Robust YoY Revenue Growth of 59.40%
Low Debt-to-Equity ratio (0.27)
Trading at a discount to book value (P/B 0.70)
Recent short-term positive price momentum (+13.2% 1W)
Key Risks
Severe liquidity shortage (Current Ratio 0.27)
Extreme operational inefficiency (Operating Margin -2969.43%)
Weak Piotroski F-Score (3/9) indicating deteriorating fundamentals
Excessive Price-to-Sales ratio (19.92) for a non-profitable entity
Significant long-term shareholder value destruction (-73.9% 3Y/5Y change)
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare GELS against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning GELS from our newsroom.
Newest → oldest
No matching news yet.